0001055726-23-000007.txt : 20230228
0001055726-23-000007.hdr.sgml : 20230228
20230228174425
ACCESSION NUMBER: 0001055726-23-000007
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230226
FILED AS OF DATE: 20230228
DATE AS OF CHANGE: 20230228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shea Jacqueline Elizabeth
CENTRAL INDEX KEY: 0001771498
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14888
FILM NUMBER: 23687836
MAIL ADDRESS:
STREET 1: C/O INOVIO PHARMACEUTICALS, INC.
STREET 2: 660 W. GERMANTOWN PIKE, SUITE 110
CITY: PLYMOUTH MEETING
STATE: PA
ZIP: 19462
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INOVIO PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001055726
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 330969592
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6769 MESA RIDGE RD.
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8584103134
MAIL ADDRESS:
STREET 1: 6769 MESA RIDGE RD.
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: INOVIO BIOMEDICAL CORP
DATE OF NAME CHANGE: 20050404
FORMER COMPANY:
FORMER CONFORMED NAME: GENETRONICS BIOMEDICAL CORP
DATE OF NAME CHANGE: 20011116
FORMER COMPANY:
FORMER CONFORMED NAME: GENETRONICS BIOMEDICAL LTD
DATE OF NAME CHANGE: 19980213
4
1
wf-form4_167762425136925.xml
FORM 4
X0306
4
2023-02-26
0
0001055726
INOVIO PHARMACEUTICALS, INC.
INO
0001771498
Shea Jacqueline Elizabeth
660 W. GERMANTOWN PIKE
PLYMOUTH MEETING
PA
19462
1
1
0
0
Chief Executive Officer
Common Stock
2023-02-26
4
M
0
22544
A
99099
D
Common Stock
2023-02-26
4
F
0
9788
1.28
D
89311
D
Common Stock
2023-02-26
4
M
0
70234
A
159545
D
Common Stock
2023-02-26
4
F
0
32485
1.28
D
127060
D
Restricted Stock Unit
2023-02-26
4
M
0
22544
0
D
Common Stock
22544.0
22544
D
Restricted Stock Unit
2023-02-26
4
M
0
70234
0
D
Common Stock
70234.0
140466
D
Common Stock Option
1.24
2023-02-27
4
A
0
836800
0
A
2023-02-27
2033-02-27
Common Stock
836800.0
836800
D
Each restricted stock unit represents a contingent right to receive one share of common stock. On February 26, 2021, the reporting person was granted 67,633 restricted stock units, vesting as follows: 22,545 shares vested on February 26, 2022; 22,544 shares vested on February 26, 2023; and 22,544 shares will vest on February 26, 2024. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein.
Each restricted stock unit represents a contingent right to receive one share of common stock. On February 26, 2022, the reporting person was granted 210,700 restricted stock units, vesting as follows: 70,234 shares vested on February 26, 2023; 70,233 shares will vest on February 26, 2024; and 70,233 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (3) herein.
The vesting schedule for the 836,800 options is as follows: 209,200 shares vested on February 27, 2023; 209,200 shares will vest on February 26, 2024; 209,200 shares will vest on February 26, 2025; and 209,200 shares will vest on February 26, 2026.
/s/ Jacqueline E. Shea
2023-02-28